Skip to main content
Cancer Questions?

Sarah Cannon Leadership and Physician Experts

Photo of Meredith McKean, MD, MPH

Meredith McKean, MD, MPH

Director, Melanoma & Skin Cancer Research, Sarah Cannon Research Institute

Dr. McKean joined Sarah Cannon Research Institute (SCRI) in 2018 and serves as director of melanoma and skin cancer research. In her role, Dr. McKean oversees investigational therapy trials for melanoma and other skin cancers.

Dr. McKean received her undergraduate degree from Iowa State University, and her Master of Public Health degree and medical degree from University of Iowa. Prior to joining SCRI, she completed her fellowship in hematology-oncology at the University of Texas MD Anderson Cancer Center. In 2017, Dr. McKean received an ASCO Conquer Cancer Foundation Young Investigator Award. She is board certified in internal medicine and medical oncology. 

Dr. McKean practices with Tennessee Oncology, PLLC, at the SCRI drug development unit in Nashville, Tenn.